Transfusion. 2002 Sep;42(9):1140-5. doi: 10.1046/j.1537-2995.2002.00171.x.
The HCV lookback program was designed to trace and offer testing to recipients who received transfusion of blood components from donors subsequently found to be anti-HCV positive. Only approximately 20 percent of transfusable components entering lookback did result in a recipient obtaining testing through this program.
Data from English blood centers were collated to describe the outcomes of the HCV lookback program. The data were used to assess factors affecting the likelihood that recipients of lookback components received testing by the program.
In total, 4424 recipients of 6687 blood components that had been issued for transfusion were identified. The lookback resulted in a tested recipient for 1067 components. Factors positively associated with receiving testing in identified recipients were younger age at transfusion, more recent year of transfusion, certain component types, and transfusion under the care of certain medical specialties; these effects were largely explained by the association of these factors with survival after transfusion.
Not accepting testing through this program was largely due to death before the lookback and partly due to inability to access information from records and to decisions that testing was not in recipients' best interests. The probability of obtaining testing through this lookback was associated with several factors that could be used to focus the efforts of similar lookbacks in the future.
丙型肝炎病毒(HCV)追溯计划旨在追踪那些接受了后来被发现抗-HCV呈阳性的献血者所捐献血液成分输血的受血者,并为他们提供检测。在进入追溯程序的可输血成分中,只有约20%最终使得受血者通过该计划接受了检测。
整理来自英国血液中心的数据,以描述HCV追溯计划的结果。这些数据用于评估影响追溯成分受血者接受该计划检测可能性的因素。
总共确定了6687份已发放用于输血的血液成分的4424名受血者。追溯导致1067份成分的受血者接受了检测。在已确定的受血者中,与接受检测呈正相关的因素包括输血时年龄较小、输血年份较近、某些成分类型以及在某些医学专科护理下接受输血;这些影响在很大程度上可由这些因素与输血后存活情况的关联来解释。
不通过该计划接受检测在很大程度上是由于在追溯之前死亡,部分原因是无法从记录中获取信息以及认为检测不符合受血者的最大利益。通过此次追溯获得检测的概率与几个因素相关,这些因素可用于指导未来类似追溯工作的重点。